SEC Form 4 · accession 0001144204-15-020559

CORCEPT THERAPEUTICS INC · CORT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners

Longitude Venture Partners L.P.

Director · 10% Owner

Longitude Capital Associates, L.P.

10% Owner

Longitude Capital Partners, LLC

10% Owner

Bakker Juliet Tammenoms

10% Owner

Period of report

Mar 30, 2015

Accepted (ET)

Apr 1, 2015 · 4:05 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001088856

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Mar 30, 2015	X	839,811	$4.05	A	14,516,932	D
Common Stock^F3	Mar 30, 2015	X	16,833	$4.05	A	194,958	I	By LCA

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Warrant (Right to Buy)^F1	$4.05	Mar 30, 2015	X	839,811	D	Mar 29, 2012	Mar 30, 2015	Common Stock	839,811	0	D
Warrant (Right to Buy)^F3	$4.05	Mar 30, 2015	X	16,833	D	Mar 29, 2012	Mar 30, 2015	Common Stock	16,833	0	I

Explanation of responses

F1Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. ("LVP"). This report is filed jointly by LVP, Longitude Capital Partners, LLC ("Longitude Capital"), the sole general partner of LVP, and Juliet Tammenoms Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LVP. LVP may also be deemed a director by virtue of its right to nominate a representative to serve on the Issuer's Board of Directors. Patrick G. Enright currently serves as LVP's representative on the Issuer's Board of Directors and files separate reports under Section 16(a) of the Securities Exchange Act of 1934 to report transactions in securities of the Issuer. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein.
F2On March 30, 2015, LVP exercised a warrant to purchase 839,811 shares of the Issuer's common stock for a cash exercise price of $4.05 per share.
F3Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Capital Associates, L.P. ("LCA"). This report is jointly filed by LCA, Longitude Capital, the sole general partner of LCA, and Ms. Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LCA. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein.
F4On March 30, 2015, LCA exercised a warrant to purchase 16,833 shares of the Issuer's common stock for a cash exercise price of $4.05 per share.